Aerie Pharmaceuticals to Present at the NASDAQ 38th Investor Conference
DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma and other diseases of the eye, today announced that Richard Rubino, Chief Financial Officer, will present at the NASDAQ 38th Investor Conference on Tuesday, June 12, 2018 at 9:00am British Summer Time in London, UK. Mr. Rubino will provide an A